Merck & Co Inc (MRK)
131.19
+0.31
(+0.24%)
USD |
NYSE |
May 17, 16:00
131.17
-0.02
(-0.02%)
Pre-Market: 20:00
Merck SG&A Expense (TTM): 10.51B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 10.51B |
December 31, 2023 | 10.50B |
September 30, 2023 | 10.39B |
June 30, 2023 | 10.39B |
March 31, 2023 | 10.20B |
December 31, 2022 | 10.04B |
September 30, 2022 | 10.18B |
June 30, 2022 | 10.00B |
March 31, 2022 | 9.77B |
December 31, 2021 | 9.634B |
September 30, 2021 | 9.423B |
June 30, 2021 | 9.147B |
March 31, 2021 | 8.951B |
December 31, 2020 | 9.319B |
September 30, 2020 | 8.429B |
June 30, 2020 | 8.958B |
March 31, 2020 | 9.585B |
December 31, 2019 | 9.455B |
September 30, 2019 | 10.37B |
June 30, 2019 | 10.22B |
March 31, 2019 | 10.02B |
December 31, 2018 | 10.10B |
September 30, 2018 | 10.10B |
June 30, 2018 | 10.12B |
March 31, 2018 | 10.11B |
Date | Value |
---|---|
December 31, 2017 | 10.07B |
September 30, 2017 | 10.28B |
June 30, 2017 | 10.21B |
March 31, 2017 | 10.17B |
December 31, 2016 | 10.02B |
September 30, 2016 | 9.784B |
June 30, 2016 | 9.863B |
March 31, 2016 | 10.03B |
December 31, 2015 | 10.31B |
September 30, 2015 | 10.62B |
June 30, 2015 | 11.12B |
March 31, 2015 | 11.47B |
December 31, 2014 | 11.61B |
September 30, 2014 | 11.66B |
June 30, 2014 | 11.49B |
March 31, 2014 | 11.66B |
December 31, 2013 | 11.91B |
September 30, 2013 | 12.32B |
June 30, 2013 | 12.58B |
March 31, 2013 | 12.69B |
December 31, 2012 | 12.78B |
September 30, 2012 | 13.09B |
June 30, 2012 | 13.37B |
March 31, 2012 | 13.64B |
December 31, 2011 | 13.73B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
8.429B
Minimum
Sep 2020
10.51B
Maximum
Mar 2024
9.774B
Average
9.886B
Median
SG&A Expense (TTM) Benchmarks
Amgen Inc | 6.729B |
Johnson & Johnson | 21.93B |
Eli Lilly and Co | 6.912B |
Pfizer Inc | 14.85B |
Moderna Inc | 1.518B |